tiprankstipranks
Trending News
More News >
AbbVie (ABBV)
NYSE:ABBV
US Market
Advertisement

AbbVie (ABBV) Ratios

Compare
22,922 Followers

AbbVie Ratios

ABBV's free cash flow for Q1 2025 was $0.70. For the 2025 fiscal year, ABBV's free cash flow was decreased by $ and operating cash flow was $0.18. See a summary of the company’s cash flow.
Ratios
TTM
Dec 24Dec 23Dec 22Dec 21
Liquidity Ratios
Current Ratio
0.76 0.87 0.96 0.79 0.84
Quick Ratio
0.64 0.76 0.84 0.70 0.73
Cash Ratio
0.14 0.34 0.31 0.28 0.29
Solvency Ratio
0.06 0.11 0.17 0.15 0.08
Operating Cash Flow Ratio
0.45 0.60 0.84 0.65 0.61
Short-Term Operating Cash Flow Coverage
3.06 3.18 6.03 1.82 2.07
Net Current Asset Value
$ -107.03B$ -91.31B$ -93.06B$ -103.17B$ -113.30B
Leverage Ratios
Debt-to-Assets Ratio
0.51 0.44 0.46 0.52 0.57
Debt-to-Equity Ratio
49.22 5.73 3.67 4.98 6.58
Debt-to-Capital Ratio
0.98 0.85 0.79 0.83 0.87
Long-Term Debt-to-Capital Ratio
0.98 0.83 0.77 0.81 0.86
Financial Leverage Ratio
95.89 13.00 8.04 9.51 11.51
Debt Service Coverage Ratio
1.32 1.69 4.68 1.80 1.82
Interest Coverage Ratio
0.85 5.74 8.12 7.40 4.63
Debt to Market Cap
0.21 0.22 0.22 0.32 0.48
Interest Debt Per Share
40.98 34.85 36.99 44.69 53.10
Net Debt to EBITDA
6.51 2.69 1.72 2.37 3.67
Profitability Margins
Gross Profit Margin
35.92%62.42%70.00%68.96%66.41%
EBIT Margin
6.17%15.85%27.06%27.42%12.78%
EBITDA Margin
17.03%31.86%54.13%50.32%46.17%
Operating Profit Margin
3.97%23.49%31.21%31.89%24.81%
Pretax Profit Margin
5.19%11.51%23.21%23.11%7.42%
Net Profit Margin
6.45%8.95%20.39%20.54%10.08%
Continuous Operations Profit Margin
4.85%8.97%20.40%20.55%10.09%
Net Income Per EBT
124.19%77.81%87.82%88.86%135.84%
EBT Per EBIT
130.77%48.99%74.39%72.47%29.90%
Return on Assets (ROA)
2.76%3.61%8.53%7.88%3.07%
Return on Equity (ROE)
85.74%46.94%68.60%74.91%35.30%
Return on Capital Employed (ROCE)
2.32%13.17%16.58%16.10%9.32%
Return on Invested Capital (ROIC)
2.74%9.56%14.04%12.87%5.57%
Return on Tangible Assets
8.88%10.39%30.19%30.22%13.35%
Earnings Yield
1.12%1.77%4.14%4.82%2.58%
Efficiency Ratios
Receivables Turnover
4.67 4.87 5.16 5.63 5.19
Payables Turnover
0.54 5.54 5.94 6.05 6.76
Inventory Turnover
3.67 4.98 4.87 5.58 4.65
Fixed Asset Turnover
11.14 10.89 11.76 11.00 8.73
Asset Turnover
0.43 0.40 0.42 0.38 0.30
Working Capital Turnover Ratio
-5.33 -18.37 -13.92 -9.56 3.11
Cash Conversion Cycle
-502.71 82.31 84.28 69.95 94.83
Days of Sales Outstanding
78.08 74.96 70.76 64.80 70.30
Days of Inventory Outstanding
99.45 73.29 75.02 65.44 78.52
Days of Payables Outstanding
680.23 65.94 61.50 60.30 53.99
Operating Cycle
177.52 148.24 145.77 130.24 148.82
Cash Flow Ratios
Operating Cash Flow Per Share
9.26 12.92 14.08 12.87 10.55
Free Cash Flow Per Share
8.68 12.48 13.69 12.42 10.07
CapEx Per Share
0.57 0.44 0.39 0.44 0.48
Free Cash Flow to Operating Cash Flow
0.94 0.97 0.97 0.97 0.95
Dividend Paid and CapEx Coverage Ratio
1.35 2.02 2.32 2.27 2.07
Capital Expenditure Coverage Ratio
16.14 29.39 35.89 28.94 22.04
Operating Cash Flow Coverage Ratio
0.23 0.38 0.39 0.30 0.20
Operating Cash Flow to Sales Ratio
0.28 0.42 0.43 0.41 0.38
Free Cash Flow Yield
4.61%8.05%8.47%9.18%9.40%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
89.01 56.34 24.18 20.76 38.70
Price-to-Sales (P/S) Ratio
5.72 5.04 4.93 4.26 3.90
Price-to-Book (P/B) Ratio
235.88 26.45 16.59 15.55 13.66
Price-to-Free Cash Flow (P/FCF) Ratio
21.70 12.42 11.80 10.90 10.64
Price-to-Operating Cash Flow Ratio
20.42 12.00 11.47 10.52 10.16
Price-to-Earnings Growth (PEG) Ratio
0.53 -0.96 9.22 0.15 -0.80
Price-to-Fair Value
235.88 26.45 16.59 15.55 13.66
Enterprise Value Multiple
40.12 18.52 10.83 10.84 12.12
Enterprise Value
398.60B 320.56B 340.28B 306.60B 256.23B
EV to EBITDA
40.12 18.52 10.83 10.84 12.12
EV to Sales
6.83 5.90 5.86 5.46 5.59
EV to Free Cash Flow
25.91 14.53 14.03 13.94 15.26
EV to Operating Cash Flow
24.30 14.04 13.64 13.46 14.57
Tangible Book Value Per Share
-52.09 -43.84 -46.48 -52.48 -61.73
Shareholders’ Equity Per Share
0.80 5.86 9.74 8.71 7.84
Tax and Other Ratios
Effective Tax Rate
-0.24 0.22 0.12 0.11 0.36
Revenue Per Share
32.92 30.72 32.78 31.75 27.48
Net Income Per Share
2.12 2.75 6.68 6.52 2.77
Tax Burden
1.24 0.78 0.88 0.89 1.36
Interest Burden
0.84 0.73 0.86 0.84 0.58
Research & Development to Revenue
0.22 0.16 0.11 0.13 0.14
SG&A to Revenue
0.01 0.20 0.23 0.18 0.21
Stock-Based Compensation to Revenue
0.03 0.01 0.01 0.01 0.02
Income Quality
1.92 4.74 2.11 1.97 3.81
Currency in USD
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis